Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages
Kohki Kawane1, Mayumi Ohtani, Keiko Miwa
1Department of Genetics, Osaka University, Osaka 565-0871, Japan.
Abstract:
A large amount of chromosomal DNA is degraded during programmed cell death and definitive erythropoiesis. DNase II is an enzyme that digests the chromosomal DNA of apoptotic cells and nuclei expelled from erythroid precursor cells after macrophages have engulfed them. Here we show that DNase II-/-IFN-IR-/- mice and mice with an induced deletion of the DNase II gene develop a chronic polyarthritis resembling human rheumatoid arthritis. A set of cytokine genes was strongly activated in the affected joints of these mice, and their serum contained high levels of anti-cyclic citrullinated peptide antibody, rheumatoid factor and matrix metalloproteinase-3. Early in the pathogenesis, expression of the gene encoding tumour necrosis factor (TNF)-alpha was upregulated in the bone marrow, and administration of anti-TNF-alpha antibody prevented the development of arthritis. These results indicate that if macrophages cannot degrade mammalian DNA from erythroid precursors and apoptotic cells, they produce TNF-alpha, which activates synovial cells to produce various cytokines, leading to the development of chronic polyarthritis.
Insights
Mice lacking DNase II develop chronic polyarthritis due to undegraded DNA. This triggers tumor necrosis factor-alpha (TNF-alpha) production, leading to joint inflammation and rheumatoid arthritis-like symptoms.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Chromosomal DNA degradation is essential during programmed cell death and erythropoiesis.
- DNase II is a key enzyme responsible for digesting DNA in apoptotic cells and erythroid precursors engulfed by macrophages.
Purpose of the Study:
- To investigate the role of DNase II in preventing autoimmune diseases.
- To elucidate the mechanism by which DNase II deficiency leads to chronic polyarthritis.
Main Methods:
- Generation and analysis of DNase II knockout (DNase II-/-) and conditional knockout mice.
- Assessment of inflammatory markers, autoantibodies, and cytokine gene expression in affected joints.
- Evaluation of the therapeutic effect of anti-tumor necrosis factor-alpha (TNF-alpha) antibody treatment.
Main Results:
- DNase II-/- mice developed chronic polyarthritis with similarities to human rheumatoid arthritis.
- Activated cytokine genes and elevated levels of anti-cyclic citrullinated peptide antibody, rheumatoid factor, and matrix metalloproteinase-3 were observed in affected joints and serum.
- Upregulation of TNF-alpha in bone marrow preceded arthritis development, and anti-TNF-alpha antibody administration prevented the condition.
Conclusions:
- Impaired DNA degradation by macrophages due to DNase II deficiency leads to TNF-alpha production.
- TNF-alpha activates synovial cells, inducing cytokine production and resulting in chronic polyarthritis.
- DNase II plays a critical role in preventing autoimmune joint inflammation.
Related Concept Videos
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Atypical Pneumonia
Chronic Inflammation: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis II: Pathophysiology


